Results 131 to 140 of about 464,004 (267)

[2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension].

, 2023
Marc Humbert, Gábor Kovács, Marius M. Hoeper, Roberto Badagliacca, Rolf M.F. Berger, Margarita Brida, Jørn Carlsen, Andrew J.S. Coats, Pilar Escribano Subías, Pisana Ferrari, Diogenes S. Ferreira, Hossein Ardeschir Ghofrani, George Giannakoulas, David G. Kiely, Eckhard Mayer, Gergely Mészáros, Blin Nagavci, Karen M. Olsson, Joanna Pepke‐Żaba, Jennifer K Quint, Göran Rådegran, Gérald Simonneau, Olivier Sitbon, Thomy Tonia, Mark Toshner, Jean-Luc Vachiéry, Anton Vonk Noordegraaf, Marion Delcroix, Stephan Rosenkranz,   +29 more
openalex   +2 more sources

Marfan Syndrome Associated With Intellectual Disability and Behavioral Anomalies: Further Evidence for the Effect of Compound Heterozygous Variants in FBN1 on Phenotypic Severity

American Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Marfan syndrome (MFS) is a rare connective tissue disorder characterized by involvement of the cardiovascular, ocular, and musculoskeletal systems. Pathogenic variants in FBN1 cause most of the MFS cases; however, intellectual disability (ID) is rarely observed. A non‐consanguineous Pakistani family with four affected individuals was recruited.
Azmatullah Khan, Naseebullah Kakar, Ainullah Kakar, Malte Spielmann, Sajid Malik   +4 more
wiley   +1 more source

Roles of Lipid Metabolism in Pulmonary Hypertension: Friend or Foe? [PDF]

Biomolecules
Huang W, Zheng R, Gong L, Zhang Y, Tan J, Cao X, Song L, Dai A.   +7 more
europepmc   +1 more source

Multimorbidity and animal models

Animal Models and Experimental Medicine, EarlyView.
Multimorbidity, defined as the coexistence of ≥2 chronic conditions, is associated with aging, genetics, and environmental factors. Animal models in multimorbidity research span three tiers: simple organisms for initial screening → rodents for mechanistic analysis → large mammals for clinical prediction.
Xinpei Wang, Yakun Ren, Xingjiu Yang, Mengyuan Li, Junxiu Liu, Xiaoyan Du, Wen Wang, Ran Gao   +7 more
wiley   +1 more source

Correction: Signaling pathways and targeted therapy for pulmonary hypertension. [PDF]

Signal Transduct Target Ther
Adu-Amankwaah J, Shi Y, Song H, Ma Y, Liu J, Wang H, Yuan J, Sun K, Hu Q, Tan R.   +9 more
europepmc   +1 more source

Exercise right heart catheterization for pulmonary hypertension identified on screening echocardiography in adult survivors of childhood cancer: A report from the St. Jude Lifetime Cohort

, 2017
Gregory T. Armstrong, James Tolle, Robert N. Piana, Aimee Santucci, James Leathers, Kirsten K. Ness, Daniel A. Mulrooney, Daniel M. Green, Vijaya M. Joshi, Leslie L. Robison, Melissa M. Hudson, Daniel J. Lenihan   +11 more
openalex   +1 more source

Clinical–Radiological Spectrum of Cerebral Amyloid Angiopathy‐Related Inflammation

Annals of Neurology, EarlyView.
Objective To identify clinical and radiological features of cerebral amyloid angiopathy‐related inflammation (CAA‐ri), and compare these features with those of sporadic CAA, to improve the understanding, diagnosis, and clinical care of CAA‐ri. Methods We retrospectively reviewed routine clinical data from 37 patients with CAA‐ri and 158 patients with ...
Larysa Panteleienko, Gargi Banerjee, Dermot Mallon, Kitti Thiankhaw, Rupert Oliver, Victoria Harvey, Gareth Ambler, Michael Zandi, Hans Rolf Jäger, David J. Werring   +9 more
wiley   +1 more source

Reversible pulmonary hypertension in a patient diagnosed with scurvy. [PDF]

BMJ Case Rep
Berra G, Genecand L, Juillet A, Deux JF, Prada P, Müller H, Roffi M, Beghetti M.   +7 more
europepmc   +1 more source

Pulmonary arterial hypertension with frequent syncope: Clinical case presentation

, 2018
A. BASHA, Shanmugam Krishnan, Jaskaran Singh Gujral, KC Goswami   +3 more
openalex   +1 more source

Everolimus in Patients with Severe Pulmonary Hypertension: A Safety and Efficacy Pilot Trial [PDF]

, 2013
Hans‐Jürgen Seyfarth, Stefan Hammerschmidt, Michael Halank, Petra Neuhaus, Hubert Wirtz   +4 more
openalex   +1 more source